Target intelligence / Profile preview

Helicobacter pylori 30S ribosomal subunit (30S subunit)

Target
30S subunit
Molecular classification
Ribonucleoprotein complex, Ribosome, Bacterial translation machinery
01

Overview

The Helicobacter pylori 30S ribosomal subunit is a fundamental component of the bacterial protein synthesis machinery, serving as the primary site for mRNA decoding and translation initiation (UniProt, 2023). It is composed of the 16S ribosomal RNA (rRNA) and approximately 21 ribosomal proteins, forming a complex that ensures the fidelity of genetic translation (PubMed: 31503231). This subunit is a major pharmacological target for antibiotics such as tetracyclines, which bind to the 16S rRNA to block the entry of aminoacyl-tRNA into the A-site, thereby halting protein production (PubChem, 2024). H. pylori infections are a primary cause of chronic gastritis and peptic ulcers, and they are strongly associated with the development of gastric adenocarcinoma and MALT lymphoma (StatPearls, 2023). The clinical efficacy of drugs targeting the 30S subunit is increasingly threatened by the emergence of resistance, often mediated by specific point mutations in the 16S rRNA gene (PubMed: 15933035). Consequently, the 30S subunit remains a focal point for structural biology and drug discovery efforts aimed at overcoming antibiotic-resistant strains of H. pylori.

Other names
Small ribosomal subunit30S ribosomeH. pylori 30S subunit16S ribosomal RNA complex
02

Mechanism of action

Inhibition of bacterial protein synthesis by binding to the 16S rRNA of the 30S ribosomal subunit, which prevents the association of aminoacyl-tRNA with the ribosomal A-site.

03

Biological functions

Protein synthesisTranslation initiationmRNA decodingtRNA binding
04

Disease associations

Helicobacter pylori infectionGastritisPeptic ulcer diseaseGastric adenocarcinomaMALT lymphoma
05

Safety considerations

Emergence of antibiotic resistance (16S rRNA mutations)Disruption of the gastrointestinal microbiota (dysbiosis)Potential for systemic toxicity with certain aminoglycosidesTreatment failure in quadruple therapy regimens
06

Interacting drugs

Tetracycline

6 more in the full profile.

07

Biomarkers

16S rRNA gene mutations (e.g., AGA 926-928 to TTC)13C-urea breath testH. pylori stool antigenRapid urease test

Beyond the preview

Go deeper on Helicobacter pylori 30S ribosomal subunit (30S subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helicobacter pylori 30S ribosomal subunit (30S subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call